NCT02093104View on ClinicalTrials.gov

TACE Study-Liver Embolization Perfusion (VGH Radiology LIU)

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Unresectable Hepatocellular CarcinomaUndergoing Chemoembolization and Radioembolization
Trial Locations (1)

V5Z1M9

Vancouver General Hospital, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT02093104 - TACE Study-Liver Embolization Perfusion (VGH Radiology LIU) | Biotech Hunter | Biotech Hunter